ConductScience.org, home

Paper33569332

Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival.

Casal-Mouriño A and 9 others. Transl Lung Cancer Res, 2021. Cited by 156 papers, by iCite.

Cite this record

ConductScience Library. Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival. Papers, record 33569332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33569332

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival.
PubMed
Journal
Transl Lung Cancer Res
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
156
iCite
Relative citation ratio, by iCite
9.18
iCite
Revised in PubMed
2024-09-02
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Casal-Mouriño AAna
2Ruano-Ravina AAlberto
3Lorenzo-González MMaría
4Rodríguez-Martínez ÁÁngeles
5Giraldo-Osorio AAlexandra
6Varela-Lema LLeonor
7Pereiro-Brea TTara
8Barros-Dios JMJuan Miguel
9Valdés-Cuadrado LLuis
10Pérez-Ríos MMónica

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118378568Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.J Clin Oncol2008https://conductscience.org/library/papers/18378568PubMed
29241071Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking.Cancer1997https://conductscience.org/library/papers/9241071PubMed
331591865Chemoradiotherapy versus radiotherapy alone following induction chemotherapy for elderly patients with stage III lung cancer.Radiat Oncol J2019https://conductscience.org/library/papers/31591865PubMed
431514942Stage III Non-small Cell Lung Cancer Management in England.Clin Oncol (R Coll Radiol)2019https://conductscience.org/library/papers/31514942PubMed
530175515Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers.Cancer Med2018https://conductscience.org/library/papers/30175515PubMed
625422491Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data.J Clin Oncol2015https://conductscience.org/library/papers/25422491PubMed
728140453Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.CA Cancer J Clin2017https://conductscience.org/library/papers/28140453PubMed
922617240Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.J Thorac Oncol2012https://conductscience.org/library/papers/22617240PubMed
1025846096Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.Lancet Oncol2015https://conductscience.org/library/papers/25846096PubMed
1131519618Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment.Anticancer Res2019https://conductscience.org/library/papers/31519618PubMed
1228885881Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.N Engl J Med2017https://conductscience.org/library/papers/28885881PubMed
1329666219Symptoms at lung cancer diagnosis are associated with major differences in prognosis.Thorax2018https://conductscience.org/library/papers/29666219PubMed
1418538025Environment And Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer.BMC Public Health2008https://conductscience.org/library/papers/18538025PubMed
1524419411A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).J Thorac Oncol2014https://conductscience.org/library/papers/24419411PubMed
1628881918Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol2017https://conductscience.org/library/papers/28881918PubMed
1726711663Is Lung Cancer Incidence Increasing in Never-Smokers?J Natl Cancer Inst2016https://conductscience.org/library/papers/26711663PubMed
1824498478Survival after Pneumonectomy for Stage III Non-small Cell Lung Cancer.Oman Med J2014https://conductscience.org/library/papers/24498478PubMed
1930630993Non-Small Cell Lung Carcinoma in Women: A Retrospective Cohort Study in Indonesia.Acta Med Indones2018https://conductscience.org/library/papers/30630993PubMed
2011165392Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis.Lung Cancer2001https://conductscience.org/library/papers/11165392PubMed
2128625632A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.Lung Cancer2017https://conductscience.org/library/papers/28625632PubMed

See all 55 referencesDownload CSV of references

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.

PMIDTitleJournalYearIn PapersSource
42959795Pancreatic involvement in lung cancer: Imaging findings and diagnostic challenges in two cases.Radiol Case Rep2026https://conductscience.org/library/papers/42959795PubMed
42865845Real-world survival outcomes following multimodal surgical treatment for stage IIIA non-small cell lung cancer.J Thorac Dis2026https://conductscience.org/library/papers/42865845PubMed
42859818Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study.Cureus2026https://conductscience.org/library/papers/42859818PubMed
42648750AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer.J Immunother Cancer2026https://conductscience.org/library/papers/42648750PubMed
42528479Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience.Future Oncol2026https://conductscience.org/library/papers/42528479PubMed
42516805A three-gene signature correlated with MAPK/ERK activation characterizes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer.Oncol Lett2026https://conductscience.org/library/papers/42516805PubMed
42512379
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315).
Cancers (Basel)2026https://conductscience.org/library/papers/42512379PubMed
42499789Clinical management and outcomes of relapsed NSCLC after chemoradiotherapy and durvalumab consolidation: real-world evidence from Germany.Ther Adv Med Oncol2026https://conductscience.org/library/papers/42499789PubMed
42475143Guideline concordance of stage IIIA non-small-cell lung cancer treatment in the Australian setting.Intern Med J2026https://conductscience.org/library/papers/42475143PubMed
42440255Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer.Clin Transl Oncol2026https://conductscience.org/library/papers/42440255PubMed
42434745Optimal treatment strategies for unresectable stage III EGFR-mutated non-small cell lung cancer: a systematic review and Bayesian network meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42434745PubMed
42366611European Cancer Prevention Organization on cancer screening: an expert panel position paper.Eur J Cancer Prev2026https://conductscience.org/library/papers/42366611PubMed
42351059Distribution and rate of lymph node metastasis following neoadjuvant chemoimmunotherapy in non-small cell lung cancer.BMC Cancer2026https://conductscience.org/library/papers/42351059PubMed
42294336Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer - implications for future research.Front Oncol2026https://conductscience.org/library/papers/42294336PubMed
42249675Stage III Non-small Cell Lung Cancer Resectability in a Country With Limited Diagnostic and Therapeutic Resources: A Colombian Expert Consensus.Cancer Control2026https://conductscience.org/library/papers/42249675PubMed
42152809Interstitial Lung Disease in Patients With Unresectable Stage III NSCLC Treated With Chemoradiotherapy Followed by Durvalumab in Japan: Analysis From the Multicenter Prospective AYAME Study.Thorac Cancer2026https://conductscience.org/library/papers/42152809PubMed
42093990Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of in vivo CAR-T platforms.Front Immunol2026https://conductscience.org/library/papers/42093990PubMed
42070217Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study.Target Oncol2026https://conductscience.org/library/papers/42070217PubMed
41975140Management of borderline resectable NSCLC: a narrative review.Clin Transl Oncol2026https://conductscience.org/library/papers/41975140PubMed
41945947The Prognostic Impact of Supraclavicular Lymph Node Metastases in Lung Cancer: Do We Need a Modification of the Current Staging System?Asian Pac J Cancer Prev2026https://conductscience.org/library/papers/41945947PubMed

See all 108 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33569332

GET https://conductscience.org/api/papers/v1/33569332/references?page=2